5th Circ. Deals Biden A Loss in Medicare Drug Pricing Row

By Mark Payne · September 20, 2024, 6:11 PM EDT

A Fifth Circuit panel majority said that a healthcare trade association has standing to challenge the Biden administration's Medicare drug pricing program, allowing the group to sidestep agency administrative procedure and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

Natl Infusion Center v. Becerra

Case Number

Court

Appellate - 5th Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

March 14, 2024

Recent Articles By Mark

October 29, 2024
Senate Panel Targets 'Clever' Pharma Pricing
October 29, 2024
HHS Hospital Pay Formula At High Court: 4 Things To Know
October 29, 2024
Latham Partner Brings Clerk Lessons To Hospital Pay Case
October 22, 2024
Medicare Advantage Star Ratings Lawsuits: 3 Things to Know
October 16, 2024
Feds Say EMTALA Trumps Idaho Abortion Ban In Emergencies
October 09, 2024
Montana High Court Upholds Temporary Abortion Ban Blocks
October 08, 2024
Lawmakers, Alcohol Industry Probe HHS Over Alcohol Recs
October 07, 2024
Justices Won't Hear Kickback Statute 'Willfulness' Case
October 07, 2024
High Court Won't Hear Emergency Care Abortion Case
October 01, 2024
11th Circ. Hearsay Ruling May Open Door To Top Court Review